References
Original article
Wang, J. et al. Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. https://doi.org/10.1016/S1470-2045(22)00224-8 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Killock, D. New CAPSTONE of SCLC therapy?. Nat Rev Clin Oncol 19, 428 (2022). https://doi.org/10.1038/s41571-022-00654-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-022-00654-w
- Springer Nature Limited